MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Impact of Chronotypes and melatonin levels on sleep disorders in patients with Parkinson’s disease

    R. Borgohain, M. Voodi, R. Kandadai, S. Meka, T. Syed, S. Turaga (Hyderabad, India)

    Objective: To investigate the sleep problems and circadian rhythm abnormalities in PD patients using sleep evaluation scale – Parkinsons disease sleep scale (PDSS) for mild…
  • MDS Virtual Congress 2020

      Individual Psychophysical Responses of Music Reward in People with/without Parkinson’s Disease using the Barcelona Music Reward Questionnaire:The Preliminary Study

    E.Y Han, J. Park (Busan, Republic of Korea)

    Objective: This study is to investigate the individual differences in musical and emotional experiences of PD patients and non-PD adults using the first Korean version…
  • MDS Virtual Congress 2020

    Self-perceived stigma and motor symptoms in patients with Parkinson’s disease

    A. Kumon, M. Sagawa, M. Saruwatari, N. Kawashima, K. Hasegawa (Sagamihara, Japan)

    Objective: To identify the variables of activities of daily living (ADL) and motor function associated with self-perceived stigma (self-stigma) in patients with Parkinson’s disease (PD).…
  • MDS Virtual Congress 2020

    Parkinson’s Disease patients with diplopia exhibit visuospatial and visuoperceptive impairment

    W. Naumann, J. Gogarten, S. Schoenfeld, F. Klostermann, F. Marzinzik, K. Schindlbeck (Berlin, Germany)

    Objective: In this study, we investigated Parkinson’s disease (PD) patients with and without diplopia using motor and non-motor assessments, including detailed neuropsychological testing. We hypothesized…
  • MDS Virtual Congress 2020

    Temporal characterization of motor, gastrointestinal, and behavioral symptoms in a SNCA A53T transgenic mouse model of Parkinson’s disease

    N. Radisavljevic, M. Cirstea, K. Bauer, B. Finlay (Vancouver, BC, Canada)

    Objective: While multiple animal models of Parkinson’s disease (PD) have been developed with varying applicability to different aspects of the disorder, no single model effectively…
  • MDS Virtual Congress 2020

    Diagnostic value of olfactory dysfunction in Parkinson’s disease

    K. Stepanchenko, V. Marchenko, A. Zhidkova (Kharkiv, Ukraine)

    Objective: To assess the olfactory performance in patients with PD using “Sniffin’ Sticks”. Background: Olfactory dysfunction is an important early premotor biomarker for PD, and…
  • MDS Virtual Congress 2020

    Olfactory dysfunction and its relationship with clinical features of Parkinson’s disease

    Y.J Zhou, R.C He, Y.W Zhao, XX. Yan, B.S Tang, J.F Guo (Changsha, China)

    Objective: To investigate the reliability of assessing olfactory function of patients with PD by HRS in China and compare other non-motor features between patients with PD…
  • MDS Virtual Congress 2020

    Sensorimotor inhibition relates to gait dysfunction in people with Parkinson’s disease

    D. Martini, G. Harker, R. Morris, J. Nutt, F. Horak (Portland, OR, USA)

    Objective: To determine how sensorimotor inhibition relates to objective measures of gait OFF and ON levodopa and how having Parkinson’s disease (PD) affects this relationship.…
  • MDS Virtual Congress 2020

    Increased epinephrine in the saliva of Parkinson’s disease patients: A preliminary observation

    P. Wichit, S. Thanprasertsuk, T. Hopetrungraung, O. Phokaewvarangkul, S. Bongsebandhu-phubhakdi, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To investigate the levels of dopamine (DA), norepinephrine (NE), epinephrine (EPI) and serotonin (5-HT) in the saliva of Parkinson’s disease (PD) patients and compare…
  • MDS Virtual Congress 2020

    Association between impulse control disorders and depression in drug-naïve Parkinson’s disease

    A. Karukote, S. Thakolwiboon, P. Julayanont (Lubbock, TX, USA)

    Objective: To determine the association between depression and impulse control disorders (ICDs) in patients with Parkinson's disease (PD). Background: Depression is one of the most…
  • « Previous Page
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley